Muley, Ajit
Kim Uh, Minji
Salazar-De Simone, Glicella
Swaminathan, Bhairavi
James, Jennifer M.
Murtomaki, Aino
Youn, Seock Won
McCarron, Joseph D.
Kitajewski, Chris
Gnarra Buethe, Maria
Riitano, Gloria
Mukouyama, Yoh-suke
Kitajewski, Jan
Shawber, Carrie J. http://orcid.org/0000-0003-2654-3559
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (RO1HL112626)
National Cancer Institute (R01CA136673, P30CA013696)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107633)
DOD Peer Reviewed Cancer Research Program (W81XWH-10-1-0304)
Lipedema Foundation (2015 Proof-of-Concept Award)
Article History
Received: 17 February 2021
Accepted: 8 October 2021
First Online: 19 October 2021
Declarations
:
: Jan Kitajewski has received research funding from Eisai Pharmaceuticals (CU12-3625 and UICID#084028 Eisai Ltd. Research Collaborative Agreements). All other authors declare that they have no conflict of interests.
: Isolation of HUVEC and HdLEC from anonymous discarded specimens and received IRB exempt status by Columbia University IRB (AAAA7338). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Mouse studies were approved by Columbia University IACUC (AC-AAAE2653, AC-AAAD0577, AC-AAAP9603, AC-AAAP0452, AC-AABB9551). All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.